Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check7 days agoChange DetectedLocations section updated to include Pennsylvania as a site, replacing the prior 'Pennsylvania Locations' entry. The revision tag was updated from v3.3.2 to v3.3.3.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed, indicating a minor metadata/version update in the page revision history with no impact on content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the generic government funding lapse notice that warned about potential data delays and NIH operating status. This note did not pertain to the study data itself. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03586024 between the old and new screenshots. Core elements such as eligibility criteria, study design, and key sections remain unchanged.SummaryDifference0.5%

- Check87 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check94 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.